The question of software patent and its patentability was discussed in June, 2014 by the Supreme Court of the United States of America (USA) in the case of Alice Corporation v CLS Bank International. It has become necessary to view the issue of software patent in a new light as it is observed that there is greater ambivalence in the law and practice of granting patent to computer implemented inventions.

A new trade agreement being negotiated between 12 countries has come under fire from health campaigners who say it will push up drug prices and weaken health services.

This paper identifies over 50 000 patents filed worldwide in various water-related technologies between 1990 and 2010, distinguishing between those related to availability (supply) and conservation (demand) technologies.

Though there are criminal remedies specifically for trademark and copyright infringement the same is not a mandate in case of patent infringement. Article 61 of TRIPS, is the sole article containing requirements for criminal procedures that signatories to the Agreement may implement.

Judgement of the Delhi High Court in the matter of Merck Sharp And Dohme Corporation and Others Vs Glenmark Pharmaceuticals dated 20/03/2015 regarding patent violation of Merck Sharp & Dohme diabetes drugs by Glenmark.

This study seeks to assess the relative impact of patent status as a component of pharmaceutical prices while controlling other market and medicine characteristics on the retail prices of oncology medicines in Thailand. Ordinary Least-Squares (OLS) regression model of log prices as a function of supply and demand factors was developed and data fitted to establish the relationship and the effects for each factor. The main finding of the model is that patented status is associated with a price of approximately 144-206% that of an equivalent generic.

The IPR Think Tank set up by the Government of India submitted its first Draft of the National IPR Policy on 19th December, 2014. The document covers an overview of India’s IP system, the vision, mission and objectives of the policy as well as the integration of IP with the Make in India and Digital India initiatives.

This publication has been developed as a handbook aimed at better understanding the intellectual property implications of the 1992 Convention on Biological Diversity and the 2010 Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits arising from their Utilization.

The pharmaceutical market in India is unique in that it is dominated by "branded" generics which enjoy a price premium though they are not superior to "unbranded" generics in either pharmacopoeia or therapeutic value. Aggressive marketing of branded generics has led to higher prices, irrational fixed dose combinations and concentration in the industry. It is high time India moved towards a de-branding of generic drugs.

Judgement of the Supreme Court of India in the matter of Dr. Aloys Wobben & Others Vs Yogesh Mehra & Others regarding intellectual property licence agreements on the manufacture of wind turbines.